GLP-1 Medications and Eating Disorder Recovery

Eating DisordersMental HealthTreatment & Recovery
Written By Elizabeth Rubin, LCSW

Holding the Complexity

GLP-1 medications are everywhere right now: in the news, on social media, in conversations with primary care providers.

For a lot of people, they are a legitimate tool for diabetes, PMOS, or other conditions. For people with a current or past eating disorder, it’s more complicated. We want to talk about that honestly, without shame, and without pretending there’s one right answer. 

When Medical Necessity and Eating Disorder History Overlap

You can need a GLP-1 for real medical reasons (blood sugar, PMOS, cardiometabolic risk), and also have a history of disordered eating. Those two things aren't in conflict just because they're both true.

If this is you, you might feel guilty, like even considering this medication is a betrayal of the work you've done to rebuild trust with food and your body. That guilt makes sense, but it's not a sign you're doing something wrong. A medication that helps your body work better and helps you feel better isn't automatically at odds with recovery. It just means this decision deserves real support, not silence, and not avoidance either.

Ask “Why,” Not “Should”

We already know how to do this with behaviors: get curious about the function something is serving instead of just judging the behavior itself. GLP-1s deserve the same approach. The useful question isn't “should this client take a GLP-1.” It’s: “what is this medication being asked to do, and does that line up with recovery or pull against it?”

A GLP-1 prescribed for insulin resistance is doing something different than one sought out because a client feels desperate to shrink their body. Same drug, different relationship to it. Getting curious about the why, with clients, and with ourselves, helps tell the difference between a tool being used for health and a new outlet for an old urge to restrict. 

Weight Stigma Shows Up in Medicine Too

We talk about societal pressure to take these medications, but the pressure isn't only cultural, it comes from providers. A larger-bodied client whose appetite drops off can have that praised as “finally getting it together,” when it's actually a warning sign. Weight stigma in medical settings means the same symptoms get read as success in a bigger body and as concerning in a thin one. That double standard delays diagnosis and leaves people without the support they need.

Thin Doesn’t Mean Healthy

Worth saying plainly: thinness isn't health, and health doesn't require thinness. People in bodies of every size can be healthy, and someone thin can have real problems underneath (deficiencies, cardiac issues, bone density loss), that get missed because their size doesn't “look like” a problem. Weight is one data point, not a stand-in for overall well-being. That matters here directly: rapid weight loss on a GLP-1 isn’t automatically good news, and a stable or higher weight isn’t automatically bad news.

The Risks Aren’t Only About Eating Disorder History

It's also worth saying clearly: GLP-1s carry real risks for anyone taking them, not just people with an eating disorder history. This isn't about scaring people away from medication that helps many; it's about informed consent which matters for every patient. 

GI Complications and Delayed Gastric Emptying

These medications slow how quickly the stomach empties, which is part of how they curb appetite. For some people that shows up as manageable nausea. For others. it progresses to gastroparesis, a stalled digestive system sometimes called “stomach paralysis”. Research has linked GLP-1 use to a small but real increase in delayed gastric emptying and retained gastric contents, which is significant enough that it now shapes pre-procedure fasting protocols before endoscopy and anesthesia.

Beyond the more serious end of that spectrum, the everyday GI side effects deserve their own attention because they're so common and can quietly reshape someone's relationship with food. Constipation is one of the most frequently reported side effects a direct result of slowed digestive motility and it can range from mildly uncomfortable to persistent and painful enough to require its own management plan. Bloating often shows up alongside it, sometimes severe enough that clients describe avoiding certain foods not because of appetite changes but because eating them reliably brings on hours of discomfort afterward.

That points to another risk worth naming directly: food aversions. Because nausea, bloating and slow digestion often get triggered by specific foods, especially those higher in fat, fiber or volume. People on GLP-1s frequently narrow what they're willing to eat, not out of restriction in the psychological sense but out of a learned association between certain foods and physical discomfort. For someone without an eating disorder history, this can still mean a diet that quietly loses variety and nutritional adequacy. For someone with an eating disorder history, this kind of narrowing can look and function a lot like restriction, even when it starts as a purely physical response, which makes it especially important to track early rather than dismiss as “just a side effect.”

Malnutrition and Nutrient Deficiencies

A 2026 review of six studies covering nearly half a million adults on GLP-1s found that a meaningful share developed deficiencies, most commonly in vitamin D, iron, and B vitamins, with anemia showing up as well. When appetite drops this much, it's not just calories that go missing: it's the micronutrients that come packaged with regular, varied eating 

Bone Density Loss

Newer data presented at the American Academy of Orthopedic Surgeons’ 2026 annual meeting found that after 5 years, GLP-1 users had a meaningfully higher risk of osteoporosis than matched controls, along with elevated risk for osteomalacia and gout. Bone health is a slow building concern that's easy to overlook when the visible focus is on weight. 

Muscle Loss

A significant portion of weight lost on these medications comes from lean muscle, not just fat. Since muscle is the tissue that drives metabolic rate, this creates a double bind: the more muscle lost, the harder the body has to work to maintain results, and the more vulnerable someone becomes to fatigue and reduced strength over time. 

Hair Loss

Rapid weight loss of any kind, medication-assisted or not, is a well-documented trigger for telogen effluvium, a temporary but distressing form of shedding. It's not unique to GLP-1s, but it's common enough with rapid loss that patients deserve a heads up rather than a surprise.

Weight Regain After Stopping

These medications aren't designed to be temporary. Obesity medicine specialists describe them as treatment for a chronic condition requiring indefinite use, and research shows that most people regain a substantial portion of lost weight within a year of stopping, partly because appetite-suppressing effects and the quieting of “food noise” both reverse once the medication clears the system. This matters clinically: the same rebound dynamic that concerns an endocrinologist managing weight can also be destabilizing for someone whose eating disorder history makes weight fluctuation itself a psychological trigger. 

The Long-Term Picture is Still Incomplete

These medications have a much longer track record for diabetes management, where doses tend to be lower and the goal is blood sugar control rather than maximal weight loss. The safety and long-term outcome data for higher-dose, weight-loss focused use is younger and still developing. Researchers analyzing five-year outcomes have said plainly that we are only now reaching the point where multi-year follow-up data exists at all.

It means there is a lot we don't know yet. 

The Risk of How Easy These Are to Get

Telehealth and compounded GLP-1s have made these medications more accessible than ever, sometimes after a brief online intake with little or no eating disorder screening. If someone hasn't disclosed their history, or isn't sure they want to tell a stranger on a video call, that is real risk. It's easy to walk away with a prescription without anyone asking the questions that would catch a fragile recovery or an active eating disorder. Convenience isn't the enemy, but it does mean the safety net that used to come from an ongoing provider relationship isn't guaranteed anymore.

What Good Collaborative Care Actually Looks Like

Ideally, anyone with an eating disorder history considering a GLP-1 has a team: a prescriber who knows the full history, a dietitian tracking food intake, a therapist checking in on the psychological piece, and all of them actually talking to each other. Regular check-ins on weight, mood, and eating patterns.

In practice, it's often one visit with a prescriber, who may never ask about eating disorder history, no loop back to the therapist or dietitian, and no real follow-up beyond a refill. Naming that gap isn't about scaring anyone off, it's so clients know what to push for. 

Questions Worth Bringing to a Prescriber

You don't have to just accept whatever’s offered. It is worth asking: 

  • “How will you monitor my progress and side effects, and how often?”

  • “What’s the plan if my appetite loss gets severe or I stop wanting to eat?”

  • “How will you track and manage GI side effects, like nausea, bloating, or constipation?”

  • “Do you know my eating disorder history, and how does that factor into your recommendation?”

  • “Would you be willing to coordinate with my therapist or dietitian?”

None of these are confrontational. They’re just informed self-advocacy. 

Both things can be true

There's no single right answer, and that's the point. GLP-1 medications can be a genuinely appropriate medical tool for many people, including people with eating disorder histories. They can also destabilize recovery for others. Both are true at once, and neither cancels out the other.

This isn't about fear, and it isn't blanket permission either. It's about informed, supported decision-making, one that includes your full history, your full care team, and room for your own honest ambivalence, without shame attached to any of it.

Resources: 

Elizabeth Rubin, LCSW

Elizabeth “Lizzye” Rubin is a Licensed Clinical Social Worker.

Lizzye’s approach is individualized and collaborative, meaning that client’s unique needs and goals for mental and emotional well-being at the forefront of the therapeutic work. Lizzye collaborates with clients in developing personalized strategies and techniques that align with their aspirations for positive change.

Next

Back-to-School Anxiety: Why School Transitions Feel So Stressful